全文获取类型
收费全文 | 413篇 |
免费 | 16篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 14篇 |
妇产科学 | 6篇 |
基础医学 | 37篇 |
口腔科学 | 5篇 |
临床医学 | 42篇 |
内科学 | 114篇 |
皮肤病学 | 4篇 |
神经病学 | 8篇 |
特种医学 | 88篇 |
外科学 | 75篇 |
综合类 | 13篇 |
预防医学 | 14篇 |
眼科学 | 3篇 |
药学 | 22篇 |
肿瘤学 | 8篇 |
出版年
2023年 | 2篇 |
2021年 | 5篇 |
2018年 | 2篇 |
2016年 | 2篇 |
2015年 | 6篇 |
2014年 | 4篇 |
2013年 | 8篇 |
2012年 | 7篇 |
2011年 | 9篇 |
2010年 | 12篇 |
2009年 | 13篇 |
2008年 | 9篇 |
2007年 | 10篇 |
2006年 | 34篇 |
2005年 | 17篇 |
2004年 | 11篇 |
2003年 | 11篇 |
2002年 | 13篇 |
2001年 | 17篇 |
2000年 | 10篇 |
1999年 | 7篇 |
1998年 | 14篇 |
1997年 | 6篇 |
1996年 | 19篇 |
1995年 | 15篇 |
1994年 | 16篇 |
1993年 | 7篇 |
1992年 | 10篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 19篇 |
1988年 | 15篇 |
1987年 | 14篇 |
1986年 | 14篇 |
1985年 | 16篇 |
1984年 | 4篇 |
1983年 | 6篇 |
1982年 | 3篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1955年 | 2篇 |
1954年 | 2篇 |
1950年 | 2篇 |
1943年 | 2篇 |
1935年 | 1篇 |
排序方式: 共有455条查询结果,搜索用时 359 毫秒
451.
BACKGROUND: Several cold autoantibodies (usually IgG) with IT specificity have been reported previously, as have autoantibodies with joint I and P blood group specificities (IP1, ITP1, iP1, IP). A fatal outcome associated with an IgM cold autoantibody of ITP specificity is reported. CASE REPORT: A 54-year-old man suffered from progressively severe cold autoimmune hemolytic anemia for 9 months. Hemoglobin concentration ranged from 6 to 7 g per dL (60-70 g/L) and reticulocytes from 3 to 5 percent (0.030-0.050). The direct antiglobulin test was weakly positive for IgM and strongly positive for C3d. The serum contained a cold agglutinin that reacted strongest with cord i red cells (RBCs) > adult I RBCs > adult i RBCs, which is consistent with IT specificity. The Donath-Landsteiner test was positive; the reaction was neutralized by globoside. The serum reacted weakly or was negative with RBCs from five group p blood donors, which suggests anti-ITP specificity. Dithiothreitol treatment of the serum abolished the cold agglutinin reactivity, which suggests that the anti-IT was IgM. The patient received > 40 RBC transfusions and failed to respond to oral steroids, oral cytoxan, high-dose pulse intravenous steroids, and plasma exchange at room temperature and at 35 degrees C. He died of sepsis following an unsuccessful trial of chlorambucil. Autopsy revealed unsuspected disseminated non-Hodgkin's lymphoma. CONCLUSION: Serologic studies are consistent with our patient's having a single IgM cold autoantibody with IT and P specificities (anti-ITP) and requiring both specificities on the same RBC to permit maximal antibody expression. 相似文献
452.
A multiply transfused patient was referred for evaluation of a transfusion reaction. The direct and indirect antiglobulin tests (DAT, IAT) for alloantibody were negative. However, IgG-coated control cells failed to agglutinate in the negative reactions, casting doubt on their validity. At 4 degrees C, the patient's serum exhibited a large cryoprecipitate (2.9 mg/mL), made up predominantly of an IgG kappa paraprotein and having trace amounts of IgM and C3. Clear serum separated at 37 degrees C became cloudy within 10 minutes at room temperature (RT); within 4 hours, approximately 60 percent of the total precipitable cryoprotein had precipitated. Red cells (RBCs) incubated in fresh serum that had cooled to RT or RBCs obtained from RT or refrigerated samples contained cryoprecipitate that sedimented with the RBCs during washing with RT saline. On resuspension, enough IgG cryoglobulin redissolved to neutralize completely the commercial anti-IgG reagents. If the patient's samples were maintained at 37 degrees C, cryoprecipitate did not form, and RBCs washed four times at 37 degrees C gave valid DAT and IAT reactions. The removal of all cryoprecipitate from the patient's serum by centrifugation after overnight incubation at 4 degrees C also made possible valid antibody screening and compatibility tests. 相似文献
453.
输入病人体内的血小板的循环能力和功能与体外保存损害和受者的体内环境有关。患有血小板减少症的住院病人,体内影响血小板存活和功能的因素比体外保存损害的影响更重要。然而人们长久以来一直认为,预测血小板成分在体内的作用可以为现行的输血措施提供有价值的参考,也可能进一步提高临床疗效,同时更有效的管理血小板贮存。确实,新的病原菌灭活方法推动了临床应用,同时可能使浓缩血小板保存更安全、保存时间更长,精确评定临床有意义的浓缩血小板质量。 保存血小板在输血后的存活和功能差异较大。如果血小板处理小心,也没有长时间保存(采集后24—48小时内)便很快 相似文献
454.
Robert J. Flamini Anne M. Comi E. Martina Bebin Michael G. Chez Gary Clark Orrin Devinsky Shaun A. Hussain Paul D. Lyons Anup D. Patel Jillian L. Rosengard Farhad Sahebkar Eric Segal Laurie Seltzer Jerzy P. Szaflarski Arie Weinstock 《Epilepsia》2023,64(8):e156-e163
The cannabidiol (CBD) Expanded Access Program (EAP), initiated in 2014, provided CBD (Epidiolex) to patients with treatment-resistant epilepsy (TRE). In the final pooled analysis of 892 patients treated through January 2019 (median exposure = 694 days), CBD treatment was associated with a 46%–66% reduction in median monthly total (convulsive plus nonconvulsive) seizure frequency. CBD was well tolerated, and adverse events were consistent with previous findings. We used pooled EAP data to investigate the effectiveness of add-on CBD therapy for individual convulsive seizure types (clonic, tonic, tonic–clonic, atonic, focal to bilateral tonic–clonic), nonconvulsive seizure types (focal with and without impaired consciousness, absence [typical and atypical], myoclonic, myoclonic absence), and epileptic spasms. CBD treatment was associated with a reduction in the frequency of convulsive seizure types (median percentage reduction = 47%–100%), and nonconvulsive seizure types and epileptic spasms (median percentage reduction = 50%–100%) across visit intervals through 144 weeks of treatment. Approximately 50% of patients had ≥50% reduction in convulsive and nonconvulsive seizure types and epileptic spasms at nearly all intervals. These results show a favorable effect of long-term CBD use in patients with TRE, who may experience various convulsive and nonconvulsive seizure types. Future controlled trials are needed to confirm these findings. 相似文献
455.
Kathleen L. Bagot PhD Tara Purvis MSc Shaun Hancock Henry Zhao PhD Skye Coote BN Damien Easton PhD Bruce C. V. Campbell PhD Steve M. Davis PhD Geoff A. Donnan PhD Shane Foster Francesca Langenberg BR Karen Smith PhD Michael Stephenson BHlthSci Stephen Bernard MD Sharon McGowan MBA Bernard Yan DMedSc Peter Mitchell MMed Sandy Middleton PhD Dominique A. Cadilhac PhD 《Journal of evaluation in clinical practice》2023,29(3):495-512